We are a team of chemists and biosensor engineers gathered around a common mission: shaping the future of biodetection for a better world. Kimialys is the result of 10 years of meticulous academic research in surface chemistry. Controlling what is happening on the surface is a fundamental aspect of biosensing techniques such as rapid tests, point-of-care diagnostics, and real-time sensors. Without the right surface interactions, even the most advanced biosensors can falter, leading to misleading results. Our research efforts have always been to optimize these crucial parameters, ensuring both precision and reliable biodetection. Founded in 2020, Kimialys is leading the charge in harnessing surface chemistry to revolutionize diagnostics and drug development, all supported by our patented K-One® technology. Building on this foundation, our coated gold nanoparticles elevate rapid diagnostic tests in terms of sensitivity, specificity and reproducibility. Additionally, our expertise in sensor chip functionalisation combined with our expertise in Surface Plasmon Resonance analysis empowers us to detect, screen, and select the most suitable biologics for both diagnostic and therapeutic applications. Reliability, robustness, and adaptability are not just benefits of our technology; they are the cornerstones of the relationships we build. For every customer we collaborate with, thousands of patients stand to benefit from our work." title="" class="btn" data-container="body" data-html="true" data-id="227541" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="Kimialys"> 2,390
Activities
Technologies
Entity types
Location
Paris, France
Paris
France
Employees
Scale: 11-50
Estimated: 18
Engaged corporates
15Added in Motherbase
1 year, 1 month agoInnovative biosensing solutions for diagnostic and pharmaceutical companies, leveraging our K-One® surface chemistry.
We are a team of chemists and biosensor engineers gathered around a common mission: shaping the future of biodetection for a better world.
Kimialys is the result of 10 years of meticulous academic research in surface chemistry. Controlling what is happening on the surface is a fundamental aspect of biosensing techniques such as rapid tests, point-of-care diagnostics, and real-time sensors. Without the right surface interactions, even the most advanced biosensors can falter, leading to misleading results. Our research efforts have always been to optimize these crucial parameters, ensuring both precision and reliable biodetection.
Founded in 2020, Kimialys is leading the charge in harnessing surface chemistry to revolutionize diagnostics and drug development, all supported by our patented K-One® technology. Building on this foundation, our coated gold nanoparticles elevate rapid diagnostic tests in terms of sensitivity, specificity and reproducibility. Additionally, our expertise in sensor chip functionalisation combined with our expertise in Surface Plasmon Resonance analysis empowers us to detect, screen, and select the most suitable biologics for both diagnostic and therapeutic applications.
Reliability, robustness, and adaptability are not just benefits of our technology; they are the cornerstones of the relationships we build.
For every customer we collaborate with, thousands of patients stand to benefit from our work.
We develop advanced gold bioconjugates for IVD and offer biomolecule screening & characterization services, leveraging our K-One® surface chemistry.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Ministère de l'Agriculture et de la Souveraineté alimentaire Government Administration | Ministère de l'Agriculture et de la Souveraineté alimentaire Government Administration | Other 21 Nov 2024 | | |
![]() UK Atomic Energy Authority Research, National and local authorities | UK Atomic Energy Authority Research, National and local authorities | Other 21 Nov 2024 | | |
![]() AXELERA Public business cluster, French Cluster, Chemical Manufacturing | AXELERA Public business cluster, French Cluster, Chemical Manufacturing | Other 13 Oct 2024 | | |
![]() Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Sep 2024 | | |
![]() Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Sep 2024 | | |
![]() Roche Pharmaceutical, Biotechnology, Biotechnology Research | Roche Pharmaceutical, Biotechnology, Biotechnology Research | Other 16 Sep 2024 | | |
![]() Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Other 2 Jun 2024 | | |
![]() RIVP Real Estate, Social Housing | RIVP Real Estate, Social Housing | Other 2 Jun 2024 | | |
![]() J'aime les Startups NGO, Think Tank, Technology, Information and Internet | J'aime les Startups NGO, Think Tank, Technology, Information and Internet | Other 16 Apr 2024 | | |
![]() Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 13 Oct 2024 | |